Skip to main content

Call for papers - Organoids: advancements in normal development and disease modeling, and Regenerative Medicine

Guest Editors

João Pedro Alves Lopes, PhD, Karolinska Institutet & Karolinska University Hospital, Sweden
Soumita Das, PhD, University of Massachusetts-Lowell, USA
Michael Sigal, PhD, Charité Universitätsmedizin Berlin & Max Delbrück Center for Molecular Medicine, Germany

Submission Status: Open   |   Submission Deadline: 15 September 2025

3D patient-derived organoids are isolated from human colonic tissue sections to model inflammatory bowel disease. The organoids are stained with DAPI (blue) for nuclei and Phalloidin (green) for cytoskeletal structures.BMC Biology is calling for submissions to our Collection on Organoids: advancements in normal development and disease modeling, and Regenerative Medicine. This Collection seeks to bring together cutting-edge research on the use of organoids as models of normal organ development and human disease, as well as transplantable material for tissue regeneration and as a platform for drug screening.

New Content ItemThis Collection supports and amplifies research related to SDG 3: Good Health and Well-Being.

Meet the Guest Editors

Back to top

João Pedro Alves Lopes, PhD, Department of Women's and Children's Health, Karolinska Institutet and Karolinska University Hospital, Sweden

Dr Alves Lopes obtained his Master’s in pharmaceutical sciences from the University of Lisbon in 2013. The year after, he moved to Sweden, where he received his PhD in Regenerative Medicine and human reproduction from Karolinska Institutet in 2018. In the same year, Dr Alves Lopes moved to the UK to conduct his postdoctoral studies at Professor Azim Surani’s lab, Gurdon Institute, University of Cambridge (2018–2022). Currently, Dr Alves Lopes is working as an Assistant Professor at the Department of Women’s and Children’s Health, Karolinska Institutet. His research uses organoids to investigate the mechanisms governing human primordial germ cell early development. Website

Soumita Das, PhD, Department of Biomedical and Nutritional Science, University of Massachusetts-Lowell, USA

Dr Das is an Associate Professor at the University of Massachusetts-Lowell. She had started the faculty position at the University of California San Diego (UCSD) and moved with her team to the University of Massachusetts-Lowell in Sept 2022. The Das lab is interested in understanding the crosstalk between epithelial cells, immune cells and microbes after exposures with toxicants and pathogens that lead to chronic inflammation. Besides basic research, her group started transdisciplinary collaborations with computational biologists, physician-scientists, and bioengineers and developed organoid-based disease models such as “Gut-in-a-dish” model for personalized therapies. Other than teaching and research, Dr Das loves to spend time with her students, fellows, and travel with her family. Website

Michael Sigal, PhD, Charité Universitätsmedizin Berlin & Max Delbrück Center for Molecular Medicine, Germany

Dr Sigal is currently a Group Leader at the Max Delbrück Center for Molecular Medicine and at the Charité Universitätsmedizin Berlin. He is professor for Translational Gastrointestinal Oncology and the Head of the Inflammatory Bowel Disease Clinic at the Virchow Klinikum of the Charité in Berlin. His lab uses organoids to study the gastrointestinal tract's epithelium, with a particular focus on tissue regeneration and host-pathogen interactions.


About the Collection

3D patient-derived organoids are isolated from human colonic tissue sections to model inflammatory bowel disease. The organoids are stained with DAPI (blue) for nuclei and Phalloidin (green) for cytoskeletal structures.BMC Biology is calling for submissions to our Collection on Organoids: advancements in normal development and disease modeling, and Regenerative Medicine. This Collection seeks to bring together cutting-edge research on the use of organoids as models of normal organ development and human disease, as well as transplantable material for tissue regeneration and as a platform for drug screening.

Studies can be based on organoids derived from either induced pluripotent stem cells or tissue-derived cells (embryonic or adult stem cells or progenitor or differentiated cells from healthy or diseased tissues, such as tumors). 

We welcome submissions focusing on studies investigating the mechanisms of self-organization and cellular differentiation within organoids, and how these processes recapitulate human tissue architecture and pathology. We are especially interested in studies addressing the issues of improving tissue patterning, specialization, and function, and avoiding tumorigenicity after transplantation of organoids. We will also consider studies that demonstrate the application of organoids in personalized medicine, such as drug screening, toxicity testing, and the identification of novel therapeutic targets.

We are interested in studies focusing on the refinement of methods to enhance the fidelity and functional maturity of organoids, especially those integrating organoid models with cutting-edge technologies such as advanced imaging, single-cell and spatial omics, microfluidic chip systems and bioprinting. 

This Collection supports and amplifies research related to SDG 3: Good Health and Well-Being.

All manuscripts submitted to this journal, including those submitted to collections and special issues, are assessed in line with our editorial policies and the journal’s peer review process. Reviewers and editors are required to declare competing interests and can be excluded from the peer review process if a competing interest exists.

Image credit: Tocci & Sayed et al, Das Lab, UMass-Lowell

There are currently no articles in this collection.

Submission Guidelines

Back to top

This Collection welcomes submission of original Research and Methodology Articles. Should you wish to submit a different article type, please read our submission guidelines to confirm that type is accepted by the journal. Articles for this Collection should be submitted via our submission system, Snapp. During the submission process you will be asked whether you are submitting to a Collection, please select "Organoids: advancements in normal development and disease modeling, and Regenerative Medicine" from the dropdown menu.

All manuscripts submitted to this journal, including those submitted to collections and special issues, are assessed in line with our editorial policies and the journal’s peer review process. Reviewers and editors are required to declare competing interests and can be excluded from the peer review process if a competing interest exists.